Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of KCNIP4 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of KCNIP4 mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 5-aza-2'-deoxycytidine | increases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Decitabine results in increased expression of KCNIP4 mRNA | CTD | PMID:21856257 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of KCNIP4 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of KCNIP4 gene | CTD | PMID:27153756 | Aflatoxin B2 alpha | increases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of KCNIP4 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of KCNIP4 mRNA | CTD | PMID:21934132 | antirheumatic drug | increases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of KCNIP4 mRNA | CTD | PMID:24449571 | arsenous acid | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of KCNIP4 mRNA | CTD | PMID:26705709 | benzo[a]pyrene | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of KCNIP4 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | affects methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of KCNIP4 5' UTR more ... | CTD | PMID:27901495 and PMID:30157460 | benzo[e]pyrene | increases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of KCNIP4 intron | CTD | PMID:30157460 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of KCNIP4 mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of KCNIP4 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of KCNIP4 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNIP4 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of KCNIP4 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KCNIP4 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol F | decreases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | bisphenol F results in decreased methylation of KCNIP4 gene | CTD | PMID:31601247 | butanal | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of KCNIP4 mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KCNIP4 gene] | CTD | PMID:28238834 | cisplatin | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of KCNIP4 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of KCNIP4 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of KCNIP4 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of KCNIP4 mRNA | CTD | PMID:19549813 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of KCNIP4 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of KCNIP4 promoter | CTD | PMID:27989131 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of KCNIP4 mRNA | CTD | PMID:23914054 | diarsenic trioxide | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of KCNIP4 mRNA | CTD | PMID:26705709 | dimethylarsinic acid | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA | CTD | PMID:34876320 | dorsomorphin | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNIP4 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of KCNIP4 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of KCNIP4 mRNA | CTD | PMID:29391264 | ethanol | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | Ethanol results in increased expression of KCNIP4 mRNA | CTD | PMID:30319688 | ethylparaben | increases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of KCNIP4 mRNA | CTD | PMID:37690743 | fulvestrant | decreases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | Fulvestrant results in decreased methylation of KCNIP4 gene | CTD | PMID:31601247 | fulvestrant | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNIP4 gene | CTD | PMID:31601247 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of KCNIP4 gene | CTD | PMID:22079235 | GW 4064 | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | GW 4064 results in increased expression of KCNIP4 mRNA | CTD | PMID:26655953 | lead(0) | affects expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Lead affects the expression of KCNIP4 mRNA | CTD | PMID:28903495 | methapyrilene | increases methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of KCNIP4 intron | CTD | PMID:30157460 | methylarsonic acid | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA | CTD | PMID:34876320 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of KCNIP4 gene | CTD | PMID:33148267 | ozone | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KCNIP4 mRNA | CTD | PMID:34911549 | PCB138 | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of KCNIP4 gene | CTD | PMID:33148267 | phenylmercury acetate | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNIP4 mRNA | CTD | PMID:27188386 | poly(I:C) | multiple interactions | EXP | | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of KCNIP4 mRNA | CTD | PMID:26923065 | progesterone | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | Progesterone results in increased expression of KCNIP4 mRNA | CTD | PMID:22238285 | rotenone | increases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Rotenone results in increased expression of KCNIP4 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | ISO | KCNIP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNIP4 mRNA | CTD | PMID:27188386 | sodium arsenate | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA | CTD | PMID:34876320 | sodium arsenite | affects methylation | ISO | KCNIP4 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of KCNIP4 gene | CTD | PMID:28589171 | sodium arsenite | multiple interactions | ISO | Kcnip4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA | CTD | PMID:34876320 | sodium arsenite | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of KCNIP4 mRNA | CTD | PMID:34032870 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of KCNIP4 mRNA | CTD | PMID:19281266 | testosterone | increases expression | ISO | Kcnip4 (Mus musculus) | 6480464 | Testosterone results in increased expression of KCNIP4 mRNA | CTD | PMID:19693291 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of KCNIP4 mRNA | CTD | PMID:26496021 | valproic acid | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of KCNIP4 mRNA | CTD | PMID:23179753 and PMID:27188386 | zoledronic acid | decreases expression | ISO | KCNIP4 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of KCNIP4 mRNA | CTD | PMID:24714768 | |